Du Pont giving $6 million for gene-splice studies

The Du Pont Company is giving Harvard Medical School $6 million for genetic research -- particularly genesplicing -- on the condition the company gets exclusive licenses to market any resulting products. The grant follows a similar 10-year agreement reached last month between the Harvard-affiliated Massachusetts General Hospital and a German drug and chemical conglomerate.

Few products have so far emerged from genetic research. There has been apparent success, however, in experimentation in humans with insulin manufactured by genetically engineered bacteria. In addition, one laboratory recently announced the development -- through the new genetic tinkering -- of a vaccine for the economically important c attle disorder called hoof-and-mouth disease.

You've read 3 of 3 free articles. Subscribe to continue.
QR Code to Du Pont giving $6 million for gene-splice studies
Read this article in
https://www.csmonitor.com/1981/0630/063014.html
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe
CSM logo

Why is Christian Science in our name?

Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that.

The Church publishes the Monitor because it sees good journalism as vital to progress in the world. Since 1908, we’ve aimed “to injure no man, but to bless all mankind,” as our founder, Mary Baker Eddy, put it.

Here, you’ll find award-winning journalism not driven by commercial influences – a news organization that takes seriously its mission to uplift the world by seeking solutions and finding reasons for credible hope.

Explore values journalism About us